BSX vs RMD: stock comparison and AI forecast
Boston Scientific Corp (BSX) and Resmed Inc (RMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BSX Boston Scientific Corp
- Market Cap
- $61.95B
- P/E Ratio
- 17.5x
- Size
- large-cap
- AI Forecast
RMD Resmed Inc
- Price
- $235.30 +13.7% · 6M
- Market Cap
- $33.10B
- P/E Ratio
- 21.4x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BSX is 1.9 times larger than RMD by market capitalization ($61.95B against $33.10B).
- BSX trades at 17.5 times trailing earnings, RMD at 21.4 times.
- RMD turns 27.8% of its revenue into net income, against 16.6% for BSX.
- BSX carries 0.76 times debt per unit of equity, against 0.38 times for RMD.
- RMD yields 1.08% in dividends; BSX pays none.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BSX | RMD |
|---|---|---|
| Market Cap | $61.95B | $33.10B |
| P/E Ratio | 17.52x | 21.43x |
| P/B Ratio | 2.42x | 5.56x |
| Dividend Yield | – | 1.08% |
| EPS | $2.44 | $10.98 |
| Book Value/Share | $17.69 | $42.29 |
| Revenue/Share | $14.54 | $40.76 |
| FCF/Share | $2.30 | $11.44 |
Profitability & Margins
| Metric | BSX | RMD |
|---|---|---|
| ROE | 13.7% | 26.8% |
| ROA | 7.7% | 19.4% |
| ROIC | 10.0% | 27.5% |
| Gross Margin | 69.1% | 61.1% |
| Operating Margin | 18.7% | 33.0% |
| Net Margin | 16.6% | 27.8% |
| EBT Margin | 17.4% | 35.1% |
| Tax Rate | 4.5% | 20.8% |
Financial Health
| Metric | BSX | RMD |
|---|---|---|
| Current Ratio | 1.36x | 2.65x |
| Quick Ratio | 0.81x | 1.88x |
| D/E Ratio | 0.76x | 0.38x |
| Financial Leverage | 1.77x | 1.38x |
| Interest Coverage | 8.3x | 99.0x |
| Working Capital | $2.18B | $2.18B |
Cash Flow
| Metric | BSX | RMD |
|---|---|---|
| Operating Cash Flow | $4.23B | $1.77B |
| Free Cash Flow | $3.33B | $1.61B |
| Capital Spending | -$903M | -$162M |
| OCF Growth YoY | -8.5% | -6.0% |
| FCF Growth YoY | -12.9% | -9.0% |
| FCF/Sales | 15.8% | 28.1% |
| CapEx/Sales | 4.3% | 2.8% |
Operational Efficiency
| Metric | BSX | RMD |
|---|---|---|
| Asset Turnover | 0.46x | 0.70x |
| Receivables Turnover | 6.8x | 5.9x |
| Inventory Turnover | 2.0x | 2.2x |
| Fixed Assets Turnover | 5.0x | 9.5x |
| Days Sales Outstanding | 54 days | 62 days |
| Days Inventory | 186 days | 167 days |
| Payables Period | 70 days | 52 days |
| Cash Conversion Cycle | 170 days | 177 days |
Income Statement
| Metric | BSX | RMD |
|---|---|---|
| Total Revenue | $21.07B | $5.73B |
| Operating Income | $3.93B | $1.89B |
| Net Income | $3.50B | $1.59B |
| R&D Expense | $2.16B | $394M |
| SG&A Expense | $7.10B | $1.18B |
| Cost of Goods Sold | $6.50B | $2.23B |
Dividend & Shareholder Information
| Metric | BSX | RMD |
|---|---|---|
| Dividends Per Share | – | $2.54 |
| Payout Ratio | – | 23.1% |
| Shares Outstanding | 1449M | 141M |
| Net Income Growth | 25.2% | 10.8% |
| EPS Growth | 69.4% | 12.4% |
BSX vs RMD: stock comparison and AI forecast
Which is bigger, BSX or RMD?
BSX is 1.9 times larger than RMD by market capitalization ($61.95B against $33.10B).
Which is cheaper on earnings, BSX or RMD?
BSX trades at 17.5 times trailing earnings, RMD at 21.4 times.
Which one does Intratio's AI model rank higher, BSX or RMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.